Stock Evaluator: Cosmos Health Inc. (COSM)

Cosmos Health Inc. COSM

$0.22 0.02 7.75%
July 31, 2026 4:00:00 PM EST November 10, 2021 Volume: 4,980,037
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Providers & Services

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. The company was founded in 2009 and is headquartered in Thessaloniki, Greece.

Commentary & Analysis


Financial Summary

Share Statistics COSM Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $11.7 $1,742.7 7%
Shares Out (Mil) 47.1 76.7 46%
Institutional Ownership 12.5% 89.7% 8%
Float (Mil) 32.8 49.4 38%
Beta 4.12 0.82 99%
Avg Daily Volume (000s) 4,196 521 91%
Price Change
(52-week)
(76.0%) 78.7% 8%
Growth COSM Industry
Median
Percentile
(All Stocks)
Sales (5yr) 3.3% 11.0% 28%
Net Income (5yr) (91.7%) (0.7%) 2%
EPS (5yr) (19.3%) 3.1% 14
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) (38.2%) (18.0%) 13%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates na na na
Current EPS $0.010 $0.010 $0.070
Month Ago EPS na na na
# Rev Up 0 1 na
# Rev Down 1 0 na
Three Months Ago EPS ($0.240) $0.080 $0.070
Year/Year Chg (116.7%) (101.6%) na
Financials COSM Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $70 $1,456 23%
Net Income (TTM) (Mil) ($21) $12 23%
EPS (TTM) ($0.594) $0.300 26%
Operating Cash Flow (TTM) (Mil) ($9) $138 20%
Net Cash Flow (TTM) (Mil) $1 $8 48%
Long-Term Debt (Q1) (Mil) $7 $316 26%
Enterprise Value (Q1) (Mil) $31 $2,170 13%
Valuation COSM Industry
Median
Percentile
(All Stocks)
P/B 0.54 2.85 10%
P/E na 26.7 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.1 na
Ratios COSM Industry
Median
Percentile
(All Stocks)
Gross Margin 10.4% 27.8% 9%
Net Margin (30.4%) 1.1% 15%
ROA (35.3%) 1.8% 15%
ROE (92.3%) 7.1% 10%
Liabilities to Assets 68.2% 59.9% 64%
F-Score 4 5 34%

Cosmos Health Inc. did not pass any screens on 7/31/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors